Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Anticancer Research|November 1, 2023
Relationship Between Daily Dose of Everolimus and Treatment Effect in Patients With Luminal HER2-negative Metastatic Breast CancerYumiko Ushiyama, Yoshiya Horimoto, Fumi Murakami, et al.
Surgical Case Reports|February 18, 2025
A Case Report of Severe Thrombocytopenic Purpura during Neoadjuvant Pembrolizumab Administration for Triple-Negative Breast CancerRyoko Semba, Shiori Tohyama, Yumiko Ushiyama, et al.
Surgical Case Reports|April 24, 2024
A case of phyllodes tumor with rapid growth during pregnancy and lactation period: a case reportShiori Tohyama, Yoshiya Horimoto, Yumiko Ushiyama, et al.
Surgical Case Reports|March 23, 2023
Acute myocarditis during adjuvant therapies for breast cancer: a case reportYumiko Ushiyama, Yoshiya Horimoto, Toshitaka Uomori, et al.
World Journal of Oncology|March 13, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data AnalysisMoe Itakura, Yoshiya Horimoto, Yumiko Ushiyama, et al.
Annals of Surgical Oncology|June 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant ChemotherapyYuko Ueki, Yoshiya Horimoto, Men Yuan, et al.
Breast Cancer (Tokyo, Japan)|July 20, 2025
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosisYuko Ueki, Yoshiya Horimoto, Kazuharu Harada, et al.
Human Pathology|May 28, 2026
Revisiting nuclear grade as a high-risk marker for predicting upgrade in ductal carcinoma in situYuko Ueki, Yoshiya Horimoto, Kazuharu Harada, et al.
Pageof 1